New Treatment Approaches Valuable For Cancer Pain, Quality Of Life
High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer
Implantable Drug Delivery Device Offers Better Pain Relief
New Drug Reverses Damage To Liver In Stem Cell Transplant
New Approach To Replacing Immune Cells Shrinks Tumors
IL13-PE38 Looks Promising In Early Tests Against Gioma
US Oncology Begins Trial Of Taxotere And Xeloda
Clinical Trials Approved In August 2002 By NCI
Trending Stories
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Former Maryland Governor Larry Hogan to receive Public Service Leadership Award from National Coalition for Cancer Survivorship
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”
